June 7th 2025
The increasing diversity and complexity of injectable drug products is driving innovation.
November 22nd 2024
Poseida Therapeutics and Takeda Partner to Develop Non-Viral In-Vivo Gene Therapy Programs
October 15th 2021In this collaboration, Takeda will utilize Poseida's biodegradable DNA and RNA nanoparticle delivery technology and other proprietary genetic engineering platforms for the research and development of gene therapies.